Close Menu

NEW YORK(GenomeWeb) – The US Patent and Trademark Office Patent Trial and Appeal Board has nullified 13 claims of a patent held by Illumina that is at the center of litigation filed by the company against Ariosa Diagnostics alleging patent infringement. 

On Wednesday, the USPTO board nullified claims 1-13 of US Patent No. 8,296,076 after an inter partes review determined that Ariosa Diagnostics, which petitioned for the review, "demonstrated by a preponderance of the evidence that the challenged claims of the … patent are unpatentable." 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

In PNAS this week: copy number changes arose during polar bear evolution, genomic and transcriptomic analysis of the Siberian hamster, and more.